Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease

Clinical and Experimental Immunology

Volumn 161, Issue 2, 2010, Pages 332-341

  Koch, S ^a   Kucharzik, T ^b   Heidemann, J ^c   Nusrat, A ^a   Luegering, A ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Municipal Hospital of Lueneburg   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

CD14; CD16; Crohn's disease; inflammatory bowel disease; monocytes

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CELL MIGRATION; CELL POPULATION; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; DISEASE ACTIVITY; ENDOTHELIUM CELL; ENTERITIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY CELL; INTESTINE MUCOSA; LAMINA PROPRIA; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MUCOSA INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD11A; C-REACTIVE PROTEIN; CELL MOVEMENT; COLITIS, ULCERATIVE; CROHN DISEASE; ENDOTHELIAL CELLS; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; INTESTINES; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTORS, IGG; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77954645351     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04177.x     Document Type: Article

References (30)

1. Mahida YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 2000 6 : 21 33.
2. Selby WS, Janossy G, Bofill M, Jewell DP. Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques. Gut 1984 25 : 32 40.
3. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007 81 : 584 92.
4. Grage-Griebenow E, Zawatzky R, Kahlert H, Brade L, Flad H, Ernst M. Identification of a novel dendritic cell-like subset of CD64(+)/CD16(+) blood monocytes. Eur J Immunol 2001 31 : 48 56.
5. Fingerle G, Pforte A, Passlick B, Blumenstein M, Strobel M, Ziegler-Heitbrock HW. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 1993 82 : 3170 6.
6. Hakkinen T, Karkola K, Yla-Herttuala S. Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII). Virchows Arch 2000 437 : 396 405.
7. Kawanaka N, Yamamura M, Aita T et al. CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 2002 46 : 2578 86.
8. Hanai H, Iida T, Takeuchi K et al. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. Am J Gastroenterol 2008 103 : 1210 16.
9. Fingerle-Rowson G, Angstwurm M, Andreesen R, Ziegler-Heitbrock HW. Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy. Clin Exp Immunol 1998 112 : 501 6.
10. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976 70 : 439 44.
11. Haraldsen G, Rugtveit J, Kvale D et al. Isolation and longterm culture of human intestinal microvascular endothelial cells. Gut 1995 37 : 225 34.
12. Helio T, Halme L, Lappalainen M et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003 52 : 558 62.
13. Passlick B, Flieger D, Ziegler-Heitbrock HW. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989 74 : 2527 34.
14. Strober W, Kitani A, Fuss I, Asano N, Watanabe T. The molecular basis of NOD2 susceptibility mutations in Crohn's disease. Mucosal Immunol 2008 1 (Suppl. 1 S5 9.
15. Ancuta P, Moses A, Gabuzda D. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions. Immunobiology 2004 209 : 11 20.
16. Ziegler-Heitbrock HW, Fingerle G, Strobel M et al. The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol 1993 23 : 2053 8.
17. Kanai T, Makita S, Kawamura T et al. Extracorporeal elimination of TNF-alpha-producing CD14(dull) CD16(+) monocytes in leukocytapheresis therapy for ulcerative colitis. Inflamm Bowel Dis 2007 13 : 284 90.
18. Weber C, Belge KU, von Hundelshausen P et al. Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol 2000 67 : 699 704.
19. Sunderkotter C, Nikolic T, Dillon MJ et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004 172 : 4410 17.
20. Haraldsen G, Kvale D, Lien B, Farstad IN, Brandtzaeg P. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol 1996 156 : 2558 65.
21. Ogawa H, Binion DG, Heidemann J et al. Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells. Am J Physiol Cell Physiol 2005 288 : C272 81.
22. Iwahashi M, Yamamura M, Aita T et al. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 2004 50 : 1457 67.
23. Wahl SM, Allen JB, Welch GR, Wong HL. Transforming growth factor-beta in synovial fluids modulates Fc gamma RII (CD16) expression on mononuclear phagocytes. J Immunol 1992 148 : 485 90.
24. Sanchez-Torres C, Garcia-Romo GS, Cornejo-Cortes MA, Rivas-Carvalho A, Sanchez-Schmitz G. CD16+ and CD16- human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4+ T cells. Int Immunol 2001 13 : 1571 81.
25. Paulsson JM, Held C, Jacobson SH, Lundahl J. In vivo extravasated human monocytes have an altered expression of CD16, HLA-DR, CD86, CD36 and CX(3)CR1. Scand J Immunol 2009 70 : 368 76.
26. Randolph GJ, Sanchez-Schmitz G, Liebman RM, Schakel K. The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med 2002 196 : 517 27.
27. Grip O, Bredberg A, Lindgren S, Henriksson G. Increased subpopulations of CD16(+) and CD56(+) blood monocytes in patients with active Crohn's disease. Inflamm Bowel Dis 2007 13 : 566 72.
28. Abreu MT, Plevy S, Sands BE, Weinstein R. Selective leukocyte apheresis for the treatment of inflammatory bowel disease. J Clin Gastroenterol 2007 41 : 874 88.
29. Dayyani F, Belge KU, Frankenberger M, Mack M, Berki T, Ziegler-Heitbrock L. Mechanism of glucocorticoid-induced depletion of human CD14+CD16+ monocytes. J Leukoc Biol 2003 74 : 33 9.
30. Smith AM, Rahman FZ, Hayee B et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 2009 206 : 1883 97.